Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1459 |
Gly-Arg-Gly-Asp-Ser
|
||
Gly-Arg-Gly-Asp-Ser (GRGDS) GRGDS is a cell binding protein domain derived from the cell-binding region of fibronectin. | |||
T10366L |
Arg-Gly-Asp-Ser acetate
Arg-Gly-Asp-Ser acetate(91037-65-9 free base) |
Integrin | Cytoskeletal Signaling |
Arg-Gly-Asp-Ser acetate 是一种整合素结合序列,可直接特异性结合 pro-caspase-8、pro-caspase-9 和 pro-caspase-3,但不结合 pro-caspase-1。它抑制整合素受体功能。 | |||
TP1459L |
Gly-Arg-Gly-Asp-Ser acetate(96426-21-0 free base)
|
Integrin | Cytoskeletal Signaling |
Gly-Arg-Gly-Asp-Ser acetate(96426-21-0 free base) 是一种源自纤连蛋白的细胞结合区域的细胞结合蛋白结构域。 | |||
TP1582 |
Gly-Arg-Gly-Asp-Ser (TFA)(96426-21-0,free)
Gly-Arg-Gly-Asp-Ser (TFA) |
||
Gly-Arg-Gly-Asp-Ser (GRGDS) is a cell binding protein domain derived from the cell-binding region of fibronectin. Osteopontin uses this motif for cell adhesion. | |||
T10366 |
Arg-Gly-Asp-Ser
Fibronectin tetrapeptide,RGDS peptide |
Others | Others |
Arg-Gly-Asp-Ser is an integrin-binding sequence that inhibits integrin receptor function. It decreases systemic inflammation via inhibition of collagen-triggered activation of leukocytes and attenuates expression of inflammatory cytokines, MMP-9, and iNOS | |||
TP1043 |
Arg-Gly-Asp-Ser (TFA)(91037-65-9,free)
Fibronectin tetrapeptide (TFA),RGDS peptide (TFA),Arg-Gly-Asp-Ser (TFA) |
||
Arg-Gly-Asp-Ser (TFA) is an integrin binding sequence that inhibits integrin receptor function. | |||
TP2347 |
Peptide 78
Peptide78,Thr-met-arg-lys-pro-arg-ser-gly-asn-pro-asp-val-ala-asn,Peptide-78 |
||
Peptide 78 is identical to peptide 74 except that serine replaces cysteine. It does not inhibit 72-kDa type IV collagenase. | |||
T83690 |
[Leu144, Arg147]-PLP (139-151) TFA
[Leu144, Arg147] Proteolipid Peptide (139-151),H-His-Ser-Leu-Gly-Lys-Leu-Leu-Gly-Arg-Pro-Asp-Lys-Phe-OH |
||
[Leu144,Arg147]-PLP (139-151)是髓鞘脂蛋白(PLP)的一种突变肽段,包含位于144和147位置的色氨酸到亮氨酸以及组氨酸到精氨酸的替换。使用[Leu144, Arg147]-PLP (139-151)(50 µg)乳化于完全弗氏佐剂(CFA)免疫后,能增加小鼠脾脏中的IL-4水平。它在体外抑制Th1细胞激活,但在体内不抑制,其中它诱导调节性T细胞的产生。用[Leu144, Arg147]-PLP (139-151)预免疫可以延迟由脑炎肽PLP (178-191)、髓磷脂少突细胞蛋白(MOG) (92-106)或髓鞘基础蛋白(MBP)在小鼠中诱导的实验性自身免疫性脑炎(EAE)的发病。 | |||
T64691 | Gly-Arg-Gly-Asp-Ser trifluoroacetate | ||
Gly-Arg-Gly-Asp-Ser trifluoroacetate 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T64691。 | |||
T75761 |
Gly-Arg-Gly-Asp-Ser TFA
GRGDS TFA |
||
Gly-Arg-Gly-Asp-Ser (TFA) 是一种与糖蛋白和骨桥蛋白在细胞结合域中起作用的五肽。该化合物能够与整合素整联蛋白受体αvβ3和αvβ5结合,其IC50值分别约为5 μM和6.5 μM。 | |||
T80142 |
Cyclo(Gly-Arg-Gly-Asp-Ser-Pro)
c(GRGDSP) |
Integrin | Cytoskeletal Signaling |
Cyclo(Gly-Arg-Gly-Asp-Ser-Pro)(c(GRGDSP))为RGD 抑制肽。该化合物作为合成的α5β1整联蛋白配体,能够竞争性阻断 invasin(Inv)与Caco-2细胞表面α5β1整联蛋白的相互结合。 | |||
T73870 |
Arg-Gly-Asp-Ser TFA
|
||
Arg-Gly-Asp-Ser (TFA) 为整联蛋白结合序列,专门抑制整联蛋白受体(integrin receptor)功能。它能够直接且特异性地与pro-caspase-8、pro-caspase-9和pro-caspase-3结合,而不与pro-caspase-1发生作用。 | |||
T80127 |
FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro
|
Integrin | Cytoskeletal Signaling |
FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro为FITC标记的GRGDSP,后者为整联蛋白(integrin)抑制剂,能阻止肿瘤细胞与血管内皮细胞粘附,进而抑制肿瘤转移。 | |||
T82633 |
Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2
|
||
Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2是源自层粘连蛋白B1链的线性肽,能够干预肿瘤细胞对基底膜的附着与侵袭,且表现出抗血管生成活性。 | |||
T76582 |
Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge:cys1-cys10)
|
||
Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge:cys1-cys10),为含环状RGD活性序列的十肽,作为整合素(Integrin)αIIbβ3的拮抗剂,能够抑制血小板与proMMP-13的粘附。 | |||
TP1092 |
Myelin Basic Protein (MBP) (68-82), guinea pig
MBP (68-82), guinea pig,豚鼠髓磷脂碱性蛋白片段68-82 |
Others | Others |
Myelin Basic Protein (MBP) (68-82), guinea pig 是一种髓鞘碱性蛋白 (MBP) 的片段。 | |||
TP1421 |
GRGDSP
|
||
Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) is used as a soluble integrin-blocking RGD-based peptide. | |||
T81186 |
SDGR
|
||
SDGR是一种四肽,含有Ser-Asp-Gly-Arg序列,能够有效抑制纤连蛋白介导的细胞附着。 |